+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diabetic Neuropathy Drug"

From
From
Diabetic Nephropathy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Diabetic Nephropathy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Diabetic Neuropathy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetic Neuropathy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Neuropathy Pain Treatment Market 2024-2028 - Product Thumbnail Image

Neuropathy Pain Treatment Market 2024-2028

  • Report
  • November 2023
  • 171 Pages
  • Global
From
Diabetic Neuropathy Drugs Market 2021-2025 - Product Thumbnail Image

Diabetic Neuropathy Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Diabetic Neuropathy Drug is a type of Central Nervous System (CNS) drug used to treat nerve damage caused by diabetes. It works by blocking the transmission of pain signals from the nerves to the brain. Commonly used drugs include anticonvulsants, antidepressants, and opioids. These drugs can help reduce pain, improve sleep, and improve quality of life. Side effects may include drowsiness, dizziness, and nausea. The Diabetic Neuropathy Drug market is a rapidly growing segment of the CNS drug market. It is driven by the increasing prevalence of diabetes, as well as the need for effective treatments for diabetic neuropathy. The market is expected to continue to grow in the coming years, as new treatments are developed and approved. Some companies in the Diabetic Neuropathy Drug market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more